Where is IMI located?

IMI is headquartered in Brussels, Belgium. It is registered at Lípová 1479 12000 Praha.

Is IMI a funded company?

IMI is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does IMI rank among its competitors?

IMI ranks 178th amongst 302 active competitors, of which 18 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of IMI?

IMI's top competitors include Anthem Biosciences, Patheon and KBI Biopharma. Among them, Abingdon Health secured the most recent funding round in October, 2025.

IMI - 2026 Company Profile & Competitors

IMI is an unfunded company based in Brussels (Belgium), founded in 2005. It operates as a Provider of drug development services for stem cells and vaccine safety. IMI has not raised any funding yet. The company has 302 active competitors, including 18 funded and 99 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and KBI Biopharma.

Company Details

Website: imi.europa.eu
Social
Registered Address: Lípová 1479 12000 Praha

Key Metrics

Founded Year

2005

Location

Brussels, Belgium

Stage

Unfunded

Ranked

178^th among 302 active competitors

Investment & Acquisitions

Exvastat & 2 more

Similar Companies

KBI Biopharma & 155 more

View IMI's full profile

IMI is associated with 6 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
Ju - 2 , s.r.o. CIN: 26136651 , Czech Republic, Active	Dec 09, 1999	-	-
INNOVATE Development 1 s.r.o. CIN: 09930558 , Czech Republic, Active	Mar 18, 2021	-	-
STAST PROJEKT s.r.o. CIN: 63984105 , Czech Republic, Active	Jun 12, 1995	-	-
EU Grant s.r.o. CIN: 27332543 , Czech Republic, Active	Aug 23, 2007	-	-
Inventive Management s.r.o. CIN: 07690096 , Czech Republic, Active	Nov 30, 2018	-	-
EURO DEVELOPMENT PROJECT 2, s.r.o. CIN: 03840379 , Czech Republic, Active	Feb 26, 2015	-	-

IMI has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of IMI include Anthem Biosciences, Patheon and KBI Biopharma. Here is the list of Top 10 competitors of IMI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2007, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 7 others	77/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	Frazier Healthcare Partners, JLL Partners ... & 3 others	75/100
3rd	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	71/100
4th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 2 others	68/100
5th	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, ADIA & 8 others	66/100
6th	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	Imperial Innovations, Invesco Perpetual & 11 others	65/100
7th	Panacea Biotec 1984, Ambala (India), Public	Developer of biosimilars, vaccines and natural products	-	India Resurgence Fund, Department of Biotechnology ... & 1 others	64/100
8th	Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired	Aseptic manufacturing CDMO providing fill-finish services for sterile injectables	$16.9M	Municipal Employees' Retirement System, Trout Creek Ventures ... & 4 others	63/100
9th	Maravai Life Sciences 2014, San Diego (United States), Public	Provides enabling tools and services in the life sciences research and bio-production industries	-	HTIF, GTCR	61/100
10th	Piramal Pharma Solutions 1988, Mumbai (India), Unfunded	Contract manufacturer of pharmaceutical products	-	-	60/100
178th	IMI 2005, Brussels (Belgium), Unfunded	Provider of drug development services for stem cells and vaccine safety	-	-	24/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on IMI's competitors? Click here to see the top ones

IMI has made 3 investments including Exvastat, Bioversys and Vibalogics. IMI has not made any acquisitions as of now.

Here is the list of its investments:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
May 13, 2020	Investments	Exvastat	2016	Cambridge (United Kingdom)
Jun 20, 2019	Investments	Bioversys	2008	Basel (Switzerland)
Jan 2015	Investments	Vibalogics	2007	Cuxhaven (Germany)